Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine (Q57208206)
Jump to navigation
Jump to search
article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine |
article |
Statements
Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: randomised controlled trial (English)
Louise Longworth
David Baldwin
Michael Moore
Judy Chatwin
Jonathan Goddard
Michael Campbell
Helen Smith
Martin Buxton
Christopher Thompson
04
0 references